tm
Seeing Is Believing
tm
Seeing Is Believing
TARS is currently covered by 5 analysts with an average price target of $72.02. This is a potential upside of $20.28 (39.2%) from yesterday's end of day stock price of $51.74.
Tarsus Pharmaceuticals 's activity chart (see below) currently has 7 price targets and 27 ratings on display. The stock rating distribution of TARS is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 42.01% with an average time for these price targets to be met of 284.5 days.
Highest price target for TARS is $72, Lowest price target is $41, average price target is $72.02.
Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 22-Jan-2025. First documented stock forecast 22-Jun-2021.
Currently out of the existing stock ratings of TARS, 18 are a BUY (85.71%), 3 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$72
$23.22 (47.60%)
$65
8 days ago
(22-Jan-2025)
2/8 (25%)
$23.89 (49.66%)
630
Hold
$41
$-7.78 (-15.95%)
$30
2 months 15 days ago
(15-Nov-2024)
2/3 (66.67%)
$-3 (-6.82%)
19
Buy
$61
$12.22 (25.05%)
$57
8 months 17 days ago
(13-May-2024)
7/9 (77.78%)
$22.63 (58.98%)
623
Buy
$60
$11.22 (23.00%)
$50
8 months 20 days ago
(10-May-2024)
2/3 (66.67%)
$23 (62.16%)
547
Buy
$49
$0.22 (0.45%)
$46
1 years 4 months 19 days ago
(11-Sep-2023)
3/3 (100%)
$32.02 (188.57%)
457
What is TARS (Tarsus Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals )?
Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals )?
Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals )?
